Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immuneering Corp

1.41
-0.1000-6.62%
Post-market: 1.40-0.0100-0.71%19:40 EDT
Volume:154.38K
Turnover:219.87K
Market Cap:50.60M
PE:-0.69
High:1.50
Open:1.47
Low:1.40
Close:1.51
Loading ...

Immuneering Is Maintained at Buy by Chardan Capital

Dow Jones
·
24 Mar

Immuneering Corp. Reports Promising Cancer Trial Results

TIPRANKS
·
22 Mar

Press Release: Immuneering Corporation Announces Grant of Inducement Award

Dow Jones
·
22 Mar

Immuneering Price Target Maintained With a $12.00/Share by Needham

Dow Jones
·
21 Mar

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Dow Jones
·
21 Mar

BRIEF-Immuneering Corporation Q4 Net Income USD 18.1 Million

Reuters
·
21 Mar

Immuneering Q4 EPS $(0.58) Misses $(0.46) Estimate

Benzinga
·
21 Mar

Immuneering Corp: Expects Its Cash Runway to Be Sufficient to Fund Operations Into 2026

THOMSON REUTERS
·
21 Mar

Immuneering Corporation Q4 EPS USD -0.58

THOMSON REUTERS
·
21 Mar

Immuneering Names DR. Igor Matushansky as Chief Medical Officer

THOMSON REUTERS
·
20 Mar

Press Release: Immuneering Names Dr. Igor Matushansky as Chief Medical Officer

Dow Jones
·
20 Mar

Immuneering (NASDAQ:IMRX) Will Have To Spend Its Cash Wisely

Simply Wall St.
·
18 Mar

Immuneering management to meet with Oppenheimer

TIPRANKS
·
07 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

Immuneering Price Target Maintained With a $12.00/Share by Needham

Dow Jones
·
07 Feb

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Palatin Technologies (PTN)

TIPRANKS
·
06 Feb

Immuneering Corp - to Sponsor Studies, Regeneron to Provide Libtayo

THOMSON REUTERS
·
06 Feb

Immuneering Announces Clinical Supply Agreement With Regeneron Pharmaceuticals to Evaluate Imm-1-104 in Combination With Libtayo® (Cemiplimab)

THOMSON REUTERS
·
06 Feb

Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)

GlobeNewswire
·
06 Feb

Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
04 Feb